Browsing tag:

type 2 diabetes mellitus


The latest news in the fight against type 2 diabetes highlights Dapagliflozin and Saxagliptin as the latest dazzling duo. Known as the brand name medications Farxiga {Dapagliflozin} and Onglyza {Saxagliptin} these powerhouse drugs have proven themselves in Phase lll trials. Data recently released from the 534 patient, three-arm trial demonstrated that the combination treatment of[…]

Read More

On January 24, 2014 the U.S. Food & Drug Administration {FDA} announced their approval for an abbreviated new drug application for anti-diabetic Repaglinide tablets. The generic formulation of the Prandin tablets, in both one and two milligram strengths will be produced by Perrigo. The advent of the abbreviated new drug application for Repaglinide is sure[…]

Read More

Exenatide, CAS number 141758-74-9 is an injectable prescription medication that helps to improve blood sugar, or glucose control in adults with type 2 diabetes mellitus.¬†Exenatide, derived from a compound found in the saliva of the Gila monster, a large lizard native to the southwestern US, is a functional analog of Glucagon-Like Peptide-1 (GLP-1), a naturally[…]

Read More

Sevelamer Hydrochloride, CAS number 152751-57-0 is efficacious when used to treat patients with kidney disease who are on dialysis. As patients with kidney disease have low blood levels of phosphorus, sevelamer binds with phosphorus in patients’ everyday diet, and prevents it from being absorbed into the blood stream. In capsule form, sevelamer is typically taken[…]

Read More

This website uses cookies. By using our site, you agree to our terms of service